Beckerhoff R, Siegenthaler W
Schweiz Med Wochenschr. 1976 Apr 3;106(14):474-7.
Primary aldosteronism and renovascular hypertension are two different diseases in which renin determinations are necessary for establishment of diagnosis or therapeutic procedure. Low renin values which are not stimulated by acute stimuli combined with elevated plasma aldosterone concentrations confirm the diagnosis of primary aldosteronism. When in a patient with proven renal artery stenosis a significant difference in renal venous renin activity is observed between the two kidneys, a connection between hypertension and renal artery stenosis is likely when in addition the renin secretion of the unaffected kidney is suppressed. A favourable outcome for surgery can be predicted when the individual clinical picture in such a case is also considered. A similar view also holds for the connection between hypertension and unilateral small kidney not due to renal artery stenosis. In essential hypertension the plasma renin level makes it possible to a certain extent to predict whether a patient will benefit from diuretics or from beta-blocking agents. Despite this experience, however, renin determinations are not indicated in every case of essential hypertension. It has not been proven that the prognosis of this disease is improved by renin oriented monotherapy rather than by effective treatment with other antihypertensive agents.
原发性醛固酮增多症和肾血管性高血压是两种不同的疾病,在这两种疾病中,肾素测定对于诊断的确立或治疗方案的制定是必要的。急性刺激不能使其升高的低肾素值,结合血浆醛固酮浓度升高,可确诊原发性醛固酮增多症。当已证实患有肾动脉狭窄的患者两侧肾脏的肾静脉肾素活性存在显著差异时,如果未受影响的肾脏的肾素分泌也受到抑制,则高血压与肾动脉狭窄之间可能存在关联。如果考虑到这种情况下的个体临床表现,手术可能会有良好的预后。对于高血压与非肾动脉狭窄所致的单侧小肾脏之间的关联,也有类似的观点。在原发性高血压中,血浆肾素水平在一定程度上可以预测患者是否会从利尿剂或β受体阻滞剂治疗中获益。然而,尽管有这些经验,但并非每例原发性高血压患者都需要进行肾素测定。尚未证实以肾素为导向的单一疗法比用其他抗高血压药物进行有效治疗能改善该疾病的预后。